500 Participants Needed

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

(RECIPE Trial)

Recruiting at 8 trial locations
LA
SJ
Overseen BySara Jacobs, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: RTI International
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once unaffiliated individuals are found using the pathways, Investigators will employ linkage coordinators (trained staff) to engage these patients in care. Participants will be asked to fill out an assessment survey which will cover areas such as previous and current treatment, clinic and hospital experience, pain, and quality of life. Participants will also be given the option of participation in a 1-hour long interview how they feel about treatment for sickle cell disease including clinic experience, pain, and quality of life?

Who Is on the Research Team?

JK

Julie Kanter, MD

Principal Investigator

University of Alabama, Birmingham (UAB)

Are You a Good Fit for This Trial?

Inclusion Criteria

I have been diagnosed with sickle cell disease.
I haven't seen a sickle cell disease specialist in over a year.
I can read and understand English.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Engagement

Participants are engaged in care using linkage coordinators to connect them with SCD specialist care

Up to 5 years

Follow-up

Participants are monitored for their affiliation with SCD-specific care and the effectiveness of engagement strategies

Up to 5 years

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Individuals diagnosed with Sickle Cell Disease (SCD) but not receiving care from an SCD specialist.Experimental Treatment1 Intervention
Individuals diagnosed with Sickle Cell Disease (SCD) but unaffiliated from SCD specialist care. These individuals will be connected to a linkage coordinator (trained staff) to provide a patient-centered approach to engagement with SCD specialist care.

Find a Clinic Near You

Who Is Running the Clinical Trial?

RTI International

Lead Sponsor

Trials
201
Recruited
942,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity